Literature DB >> 9674759

Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation.

C Geula1.   

Abstract

Severe pathology in Alzheimer's disease (AD) results in marked disruption of cortical circuitry. Formation of neurofibrillary tangles, neuronal loss, decrease in dendritic extent, and synaptic depletion combine to halt communication among various cortical areas, resulting in anatomic isolation and fragmentation of many cortical zones. The clinical manifestation of this disruption is severe and debilitating cognitive dysfunction, often accompanied by psychiatric and behavioral disturbances and a diminished ability to perform activities of daily living. However, different cortical circuits are not equally vulnerable to AD pathology. In particular, two cortical systems that appear to be involved in the neural processing of memory are selectively vulnerable to degeneration in AD. One consists of connections between the hippocampus and its neighboring cortical structures within the temporal lobe. The second is the cortical cholinergic system that originates in neurons within the basal forebrain and innervates the entire cortical mantle. The circuitry in these systems shows early and severe degenerative changes in the course of AD. The selective vulnerability of these circuits is the probable reason for the early and marked loss of memory observed in these patients. This review presents current knowledge of the general pattern of cortical circuitry, followed by a summary of abnormalities of this circuitry in AD. The cortical circuits that exhibit selective pathology in AD are described in greater detail. Therapeutic implications of the abnormal circuitry in AD are also discussed. For therapies to be effective, early diagnosis of AD is necessary. Future efforts at AD therapy must be combined with an equally intense effort to develop tools capable of early diagnosis of AD, preferably at a preclinical stage before the onset of cognitive symptoms.

Entities:  

Mesh:

Year:  1998        PMID: 9674759     DOI: 10.1212/wnl.51.1_suppl_1.s18

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  44 in total

1.  Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice.

Authors:  A L Phinney; T Deller; M Stalder; M E Calhoun; M Frotscher; B Sommer; M Staufenbiel; M Jucker
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 2.  Cholinergic therapy for neuropsychiatric symptoms in neurologic disorders.

Authors:  D I Kaufer
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

3.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease.

Authors:  G A Marshall; D I Kaufer; O L Lopez; G R Rao; R L Hamilton; S T DeKosky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

Review 5.  Long-term cholinesterase inhibitor treatment of Alzheimer's disease.

Authors:  Peter Johannsen
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 6.  The declining infrastructure of the aging brain.

Authors:  David H Salat
Journal:  Brain Connect       Date:  2011

7.  Fornix deep brain stimulation circuit effect is dependent on major excitatory transmission via the nucleus accumbens.

Authors:  Erika K Ross; Joo Pyung Kim; Megan L Settell; Seong Rok Han; Charles D Blaha; Hoon-Ki Min; Kendall H Lee
Journal:  Neuroimage       Date:  2016-01-11       Impact factor: 6.556

8.  A novel p75NTR signaling pathway promotes survival, not death, of immunopurified neocortical subplate neurons.

Authors:  M F DeFreitas; P S McQuillen; C J Shatz
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

9.  Visual association test to detect early dementia of the Alzheimer type.

Authors:  J Lindeboom; B Schmand; L Tulner; G Walstra; C Jonker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

Review 10.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.